This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
India currently hosts more than 10,075 biotech startups
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Subscribe To Our Newsletter & Stay Updated
